(1 - 14 from 16
)
Google News: Regulatory pressures could help end CMO slump; analyst
[OutSourcing-Pharma.com] - At the Wells Fargo Securities Healthcare Conference last week, James Mullen, CEO of Patheon, said it is a “miracle” CMOs win business when they are
Google News: Tighter GMPs a significant risk for Indian drugmakers; CARE
[In-PharmaTechnologist.com] - Last week James Mullen, CEO of Patheon, said it is winning business on the back of regulatory actions against its competitors and major biopharma companies.
Patheon hikes revenue guidance for 2012
www.inpharm.com
[InPharm] quarter is very encouraging, as we are winning new business and growing existing customer relationships", said Patheon's chief executive James Mullen.
SD 500: James J. Mullen III | San Diego Business Journal
www.sdbj.com
James Mullen brings a unique scientific background to his legal practice. He has a doctorate in biomedical sciences and worked in various ...
sorted by relevance / date